
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
After a few moments of perusing status updates and photos of friends on Facebook, an ad caught Michael Banko's eye. The ad sought participants in a study for an HIV/AIDS vaccine. This wasn't Banko first association with HIV awareness, research, and prevention. In 2006, he raised money to run the National AIDS Marathon. But becoming a vaccine volunteer, he decided, was his duty. 'I consider myself a fairly healthy gay male, and I've been lucky as far as the whole HIV/AIDS thing goes,' he says. 'But I knew I could do my part to help others as well.' After Banko threw his hat into the ring he was subject to several rounds of paperwork, blood work, screening, and interviews. Michele Vertucci, the clinic manager at the AIDS Research Alliance in Los Angeles, says that potential participants must first share their medical background and lifestyle habits during a telephone interview. Once advancing past that round, candidates come in to the clinic for a screening appointment, which involves the signing of a thorough consent form. After which, Vertucci or another administrator meets with the candidates individually to outline everything they face during the trial, including the length of the study and the basics of vaccine or treatment trials. Trials for vaccines like Banko's typically lasts 3-5 years, while trials for treatment drugs like Merck's Isentress drug, which the ARA evaluated, last up to two years. In either case, it's a substantial commitment, and research organizations like the ARA want to make sure that participants are dedicated to checking in regularly and staying on top of their health. During the testing phase, volunteers are either given a placebo, or the real drug or vaccine. They're then expected to to report regularly on their health and to be screened for changes in their condition. The ARA's current vaccine study only has 55 enrolled. Vertucci acknowledges that some potential candidates for study don't even consider participating in the AIDS vaccine trials due to the fear that they might contract the virus, or because society's view on HIV has changed. 'Back in 1998, we tested the first [AIDS] vaccine study in the U.S.,' she says. 'At that time, we first screened 400 people, and enrolled 200 into the study. In 1998, there was a shared knowledge among the community that we needed a vaccination. And I think, with this current vaccine study, it's been more difficult in some ways to recruit people than it was in 1998. It's a different atmosphere. Now, it's no longer viewed as a fatal disease. Young people now just don't think they'll get infected, or others have a fatalistic approach.' As for fears about becoming infected via a vaccine, Vertucci says that shouldn't be a concern. 'If we were doing something like a hepatitis B study, people wouldn't have the same fears, or concerns,' Vertucci says. 'The HIV is man-made in a lab, so a person can't get HIV from the vaccine, and you can't give it to a partner. It's not a live virus. Once people hear that, then they're like, 'Oh, O.K., yeah, I can do this.' It's just like when you were a kid and you got a polio vaccination.' Some study participants agree to be in trials for the small compensation. Others take the opportunity to try treatment drugs that have not been released to the market, but could still help counter disease symptoms or treatment side effcts, like diarrhea or lipodystrophy. Testers like Banko do it because he knows it could help pave the way for a world without AIDS. 'My friends who are HIV-positive, seem to be thankful,' he says. 'Even though it won't be helping them, unfortunately, they understand why this is so necessary.'
From our Sponsors
Most Popular
Why activist Raif Derrazi thinks his HIV diagnosis is a gift
September 17 2024 12:00 PM
Out100 Honoree Tony Valenzuela thanks queer and trans communities for support in his HIV journey
September 18 2024 12:00 PM
How fitness coach Tyriek Taylor reclaims his power from HIV with self-commitment
September 19 2024 12:00 PM
Creator and host Karl Schmid fights HIV stigma with knowledge
September 12 2024 12:03 PM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
Eureka is taking a break from competing on 'Drag Race' following 'CVTW' elimination
August 20 2024 12:21 PM
Plus: Featured Video
Latest Stories
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
SFAF's Dr. Tyler TerMeer says he'll continue to fight for health care for all
January 28 2025 3:00 PM
Lexi Love goes public with HIV status after Trump wipes resources from federal website
January 23 2025 11:23 AM
Plus nominated for 2025 GLAAD Media Award alongside industry giants like Vogue, People, and Variety
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Check out our 2024 year-end issue!
October 28 2024 2:08 PM
Meet our Health Hero of the Year, Armonté Butler
October 21 2024 12:53 PM
AIDS/LifeCycle is ending after more than 30 years
October 17 2024 12:40 PM
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
October 15 2024 5:03 PM
Kentucky bans conversion therapy for youth as Gov. Andy Beshear signs 'monumental' order
September 18 2024 11:13 AM
Study finds use of puberty blockers safe and reversible, countering anti-trans accusations
September 11 2024 1:11 PM
Latinx health tips / Consejos de salud para latinos (in English & en espanol)
September 10 2024 4:29 PM